Core Viewpoint - Owens & Minor has agreed to sell its Products & Healthcare Services (P&HS) segment to Platinum Equity for $375 million in cash, allowing the company to focus on home-based care operations [1][4]. Group 1: Transaction Details - The sale price for the P&HS segment is $375 million in cash, with Owens & Minor retaining a 5% equity stake and over $150 million in tax attributes [1][2]. - The transaction will be finalized by the end of the year, pending regulatory review and customary closing conditions [4]. - Owens & Minor will receive the cash payment at closing, subject to adjustments for transaction expenses, working capital, and net debt [2]. Group 2: Business Focus and Strategy - The P&HS segment operates as a vertically integrated platform for distributing medical supplies, primarily serving the acute-care market [2]. - The sale is part of Owens & Minor's strategic transformation into a leading, pure-play home-based care platform, as stated by the company's president and CEO Edward Pesicka [3][4]. - The company aims to drive more value for its patient direct stakeholders through this transformation [4]. Group 3: Future Prospects - Owens & Minor will retain a preferred equity return, which may allow it to receive a portion of future divestiture proceeds [3]. - Platinum Equity's co-president expressed confidence in the future of the P&HS segment and the partnership with Owens & Minor [5].